Dimension Vista and 1 more
Immunochemical, Ceruloplasmin. 510(k) K063655, from Dade Behring, Inc. (Newark, DE). Product code CHN, class 2.
As of Nov 19, 2026, K063655 is an FDA 510(k) held by Dade Behring, Inc., substantially equivalent on Feb 15, 2007 after 69 days, with no recalls tied to it in FDA's recall database.
- Review time: 69 days
- Recalls: 0
Dimension Vista™ CER Flex® reagent cartridge: The CER method is an in vitro diagnostic test for the quantitative determination of Ceruloplasmin in human serum, heparinized plasma or EDTA plasma on the Dimension Vista® System. Measurements of ceruloplasmin aid in the diagnosis of copper metabolism disorders.
- N Antisera To Human CeruloplasminK053074 · Dade Behring, Inc. · Mar 16, 2006
- Modification To N Protein Standard SLK012470 · Dade Behring, Inc. · Sep 28, 2001
- Modification To N/T Protein Control SLK012468 · Dade Behring, Inc. · Sep 4, 2001
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Dec 8, 2006
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5210
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files